DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Gilead Sciences (NASDAQ: GILD)

111.71 0.49 (0.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $111.71 0.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $110.70
Previous Close $111.22
Daily Range $110.70 - $112.66
52-Week Range $78.50 - $116.83
Market Cap $164.2B
P/E Ratio 12.67
Dividend (Yield) $1.72 (1.5%)
Ex-Dividend Date
Dividend Pay Date
06/12/15
06/29/15
Volume 12,076,430
Average Daily Volume 11,216,000
Current FY EPS $11.04

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary

Warren Buffett's Portfolio: 3 Biotech Stocks the Oracle of Omaha Could Love

If you're reading, Mr. Buffett, here are three biotech stocks you'd likely love.

FireEye, Gilead Sciences, and Aeropostale: Doug Kass' Views

Healthcare Investment Opportunities for the Long Term

Three healthcare investment opportunities that could be profitable for decades to come.

The Most Loved Biotechs of Big Hedge Funds

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Kite Pharma Starts Dosing in Phase I/II Study on KTE-C19 - Analyst Blog

5 Dividend Companies With 10-15% Growth

J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog

Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog

Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog

Achillion Pharmaceuticals: Should You Buy After The Sell-Off?

See More GILD News...

GILD's Top Competitors

GILD $111.71 (0.44%)
Current stock: GILD
AMGN $163.59 (-0.15%)
Current stock: AMGN
CELG $116.09 (-0.09%)
Current stock: CELG
$0.00 (0.00%)
Current stock: